Sarcopeniatocilizumabrheumatoid arthritisprednisoneRATNF-i
…pean League Against Rheumatism (EULAR) classification criteria. Sarcopenia was diagnosed based on the AWGS 2025 consensus, using bioelectr…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 116 of 2459Caris Life SciencesRCCmetastatic renal cell carcinomaICIs
…n=18 post-treatment). Whole-exome and RNA-seq were performed at Caris Life Sciences.Results In this limited cohort, pretreatment responder biopsies…
RASilupus nephritisSTARSLELN
…pendent predictors of CRR, but not RASi usage.Conclusion Adding RASi to standard induction therapy provided no additive benefit for …
retatrutideTirzepatidesomatostatinhyperaminoacidemiatype 2 diabeteshyperglucagonemialiver steatosisT2Dglucose-lowering therapiesInsulin+2 more
…oncentrations, and similar observations have been reported with retatrutide despite its glucagon receptor agonist activity.9 Whether these …
CRCMITScolorectal cancerSITH. pylori treatment
…ns of H. pylori infection and H. pylori treatment with incident CRC risk and evaluated whether these associations were modified by …
epcoritamabglofitamabmosunetuzumabhaemophagocytic lymphohistiocytosisprogressive multifocal leukoencephalopathydisseminated intravascular coagulationdisseminated tuberculosis
… for several AEs not currently listed in product labelling. For epcoritamab, unlabelled signals included progressive multifocal leukoenceph…
azithromycindomperidonealimemazineaprepitantMyotonic dystrophyCerebral palsyGastrointestinal dystonia (GID)Wang syndrome
…ed despite infection resolution. Multiple prokinetics including azithromycin, domperidone, and alimemazine were ineffective, with ongoing ga…
InfliximabCrohn’s ColitisCrohn’s diseasePIBDulcerative colitispaediatric inflammatory bowel disease (PIBD)
…t; 10/23 (43%) patients with available levels were below target.Infliximab is a highly effective therapy in PIBD but adequate induction do…
COVID-19AspirinGastric ulcersamoxicillinclarithromycindiet modification
… Five days into hospitalization, the infant tested positive for COVID-19.3Treatment included intravenous omeprazole, diet modification, …
butyrateNSCLCnon-small cell lung cancerClostridium butyricumbutyrate-producingmouse models
…n vivo and in vitro through the gut-lung axis. Mechanistically, butyrate activated GPR109A-FOXO1 signaling and suppressed fatty acid oxi…
Crohn’s diseaseintestinal fibrosisCapsaicinKynACGRPCGRP-treatedinflammatory bowel diseases
…KynA stimulated TRPV1+ neurons and might predispose a subset of Crohn’s disease patients to more severe intestinal fibrosis. (IDDF2026-ABS-0215…
[18F]FDGCRC[ 18F]FDGColorectal cancer[68Ga]Ga-HKF-020[ 68Ga]Ga-HKF-020[68Ga]Ga-FAP2286
…ing. Ongoing studies will include head-to-head comparisons with [18F]FDG and 177Lu-labeling to further explore its value in CRC theranos…